Biosafety Level 4 - Infectious Diseases

Relevant Publications

Design and Application of Biosafe Coronavirus Engineering Systems without Virulence.

Issue Release: 2024

VLP-based model for the study of airborne viral pathogens.

Issue Release: 2024

Development of a vesicular stomatitis virus pseudotyped with herpes B virus glycoproteins and its application in a neutralizing antibody detection assay.

Issue Release: 2024

Inactivation Validation of Ebola, Marburg, and Lassa Viruses in AVL and Ethanol-Treated Viral Cultures.

Issue Release: 2024

Nanosized Porphyrin-Containing Covalent Organic Polymer to Enhance Ferroptosis in Photodynamic Treatment of Tumor Cells via Glutathione Depletion.

Issue Release: 2024

Acetic Acid Enables Molecular Enumeration of Mycobacterium tuberculosis from Sputum and Eliminates the Need for a Biosafety Level 3 Laboratory.

Issue Release: 2024

Updated Insights into the Phylogenetics, Phylodynamics, and Genetic Diversity of Nipah Virus (NiV).

Issue Release: 2024

Establishment of a novel minigenome system for the identification of drugs targeting Nipah virus replication.

Issue Release: 2024

Comparative study of the propagation and plaque titration conditions for human coronavirus OC43 as a surrogate for SARS-CoV-2.

Issue Release: 2024

Heat Inactivation of Nipah Virus for Downstream Single-Cell RNA Sequencing Does Not Interfere with Sample Quality.

Issue Release: 2024

Preservation of scRNA-Seq Libraries Using Existing Inactivation Protocols.

Issue Release: 2024

Evaluation of fendiline treatment in VP40 system with nucleation-elongation process: a computational model of Ebola virus matrix protein assembly.

Issue Release: 2024

The SARS-CoV-2 M Dimer-Based Screening System: A Synthetic Biology Tool for Identifying Compounds with Dimerization Inhibitory Potential.

Issue Release: 2024

The biosafety incident response competence scale for clinical nursing staff: a development and validation study.

Issue Release: 2024

Establishment and application of a surrogate model for human Ebola virus disease in BSL-2 laboratory.

Issue Release: 2024

Novel transcription and replication-competent virus-like particles system modelling the Nipah virus life cycle.

Issue Release: 2024

An mRNA-LNP-based Lassa virus vaccine induces protective immunity in mice.

Issue Release: 2024

HuR (ELAVL1) regulates the CCHFV minigenome and HAZV replication by associating with viral genomic RNA.

Issue Release: 2024

Serum AZD7442 (tixagevimab-cilgavimab) concentrations and IC values predict SARS-CoV-2 neutralising antibody titres.

Issue Release: 2024

Ferroptosis is involved in human chorionic trophoblast cells cytotoxicity induced by black phosphorus nanoparticles.

Issue Release: 2024

What Technologies Are Used in Proteomics?

What is Genomic Sequencing?

How Can Pregnant Women Reduce the Risk of Infections?

What Do Blood Test Results Mean?

What are Some Examples of Protein Targets in Pathogens?

What Challenges Exist in Targeting Structural Proteins?

What are the limitations of RT-PCR?

What is Plasmodium?

What are the Challenges in Controlling Anopheles Mosquitoes?

What are the global statistics?

Partnered Content Networks

Relevant Topics